The study analyzed adverse events rates and cost of care for total knee arthroplasty.
ConforMIS financially supported the study, which involved 248 TKA patients treated at one facility by the same surgeon. The surgeon treated patients with a customized knee implant, designed for a unique anatomy, or an off-the-shelf implant, chosen from a pre-manufactured size.
Here are six observations:
1. Researchers found a smaller percentage of customized implant TKA patients had adverse events at discharge and 90 days after discharge, compared to off-the-shelf implant TKA patients.
2. Compared to off-the-shelf implant TKA patients, a greater percentage of customized implant TKA patients were discharged in less than three days.
3. A smaller percentage of customized implant TKA patients went into a rehabilitation center or post-acute care facility following discharge, compared to off-the-shelf implant TKA patients.
4. Of the patients, fewer of those treated with customized implants received a blood transfusion.
5. The study revealed the total average real hospital costs to be similar between the two groups, implying customized implants improve outcomes at no additional cost.
6. The risk-adjusted per patient total cost of care revealed a net savings of $913.87 for each patient in the customized implant group for bundle of care.
More articles on devices:
Global spinal fusion devices market valued at $7.435M by 2022: 7 highlights
6 trends in the personalized orthopedic market
Amedica reports preliminary 2016 revenue of $15.2M — 10 highlights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
